| Literature DB >> 22719933 |
Yu Kang1, Rui Deng, Can Wang, Tao Deng, Peichao Peng, Xiaoxing Cheng, Guoqing Wang, Minping Qian, Huafang Gao, Bei Han, Yusheng Chen, Yinghui Hu, Rong Geng, Chengping Hu, Wei Zhang, Jingping Yang, Huanying Wan, Qin Yu, Liping Wei, Jiashu Li, Guizhen Tian, Qiuyue Wang, Ke Hu, Siqin Wang, Ruiqin Wang, Juan Du, Bei He, Jianjun Ma, Xiaoning Zhong, Lan Mu, Shaoxi Cai, Xiangdong Zhu, Wanli Xing, Jun Yu, Minghua Deng, Zhancheng Gao.
Abstract
UNLABELLED: Etiologic diagnoses of lower respiratory tract infections (LRTI) have been relying primarily on bacterial cultures that often fail to return useful results in time. Although DNA-based assays are more sensitive than bacterial cultures in detecting pathogens, the molecular results are often inconsistent and challenged by doubts on false positives, such as those due to system- and environment-derived contaminations. Here we report a nationwide cohort study on 2986 suspected LRTIEntities:
Mesh:
Year: 2012 PMID: 22719933 PMCID: PMC3375278 DOI: 10.1371/journal.pone.0038743
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1A flow chart of patient recruitment and sample processing.
After admission, we collected 4 sputum samples from each patient. The same samples are used for the parallel qLAMP and culture tests. The results from qLAMP and one-time culture are from the same sample, and those of qLAMP and three-time culture are from the same patient, but not the same sample.
Figure 2qLAMP and culture result from LRTI patients.
(A) The positive rates (the right vertical axis) of one-time culture (brown bar), three-time culture (blue bar), and quantitative LAMP (yellow bar) for the eight species in the panel (from the left: Ab, A. baumannii; Ec, E. coli; Hi, H. influenzae; Kp, K. pneumoniae; Pa, P. aeruginosa; Sa, S. aureus; Sm, S. maltophilia; and Sp, S. pneumoniae) detected from the number of patients (the left vertical axis). (B) The number of patients (the left vertical axis) who were tested positive for at least one bacterium in one-time culture, three-time culture, and qLAMP. Each bar is the sum of patient with single (blue bar) and multiple (yellow bar) species detected.
Data Summary of qLAMP and culture assays.
| Ab | Ec | Hi | Kp | Pa | Sa | Sm | Sp | |||||||||
| qLAMP | + | − | + | − | + | − | + | − | + | − | + | − | + | − | + | − |
| 220 | 1313 | 102 | 1431 | 194 | 1339 | 244 | 1289 | 200 | 1333 | 140 | 1393 | 227 | 1306 | 190 | 1343 | |
| Total Culture | 25 | 33 | 14 | 24 | 6 | 12 | 34 | 26 | 58 | 39 | 28 | 25 | 10 | 11 | 27 | 21 |
| Three-time Culture | 23 | 30 | 10 | 21 | 6 | 12 | 21 | 22 | 55 | 38 | 12 | 18 | 9 | 8 | 15 | 18 |
| One-time Culture | 6 | 5 | 7 | 4 | 0 | 0 | 22 | 5 | 3 | 1 | 24 | 7 | 3 | 3 | 16 | 3 |
| ConfirmedCulture | 9 | 8 | 7 | 5 | 1 | 0 | 12 | 4 | 16 | 12 | 8 | 2 | 2 | 0 | 6 | 0 |
| Confirmationrate | 0.36 | 0.24 | 0.5 | 0.208 | 0.17 | 0.00 | 0.35 | 0.154 | 0.27 | 0.307 | 0.285 | 0.08 | 0.2 | 0.00 | 0.222 | 0 |
| Bacterial Mortality | 0.792 | 0.64 | 1.0 | 0.372 | 0.957 | 0.00 | 0.647 | 0.424 | ||||||||
Note: The Abbreviations are: Ab, A. baumannii; Ec, E. coli; Hi, H. influenzae; Kp, K. pneumoniae; Pa, P. aeruginosa; Sa, S. aureus; Sm, S. maltophilia; and Sp, S. pneumonia.
indicates the number of patients whose positive culture was confirmed by one of the 4 culture-based tests.
indicate confirmation rate of the positive cultures by one of the 4 culture-based tests.
indicate the bacterial mortality due to refrigeration, storage, and transportation.
Relatedness between qLAMP and culture assays and cutoffs in different subgroups.
| Cutoff (copies/ml) | Contingency table | Logistic regression model | Positive rate under the titer of 103copies/ml | ||||
| Lower | Upper |
|
| Estimated | Actual | ||
| Ab | All | N | 2.07×105 | 1.92×10−10 | 1.08×10−10 | 0.0380 | 0.0229 |
| Ec | All | N | 6.67×104 | 1.31×10−14 | 1.70×10−8 | 0.0282 | 0.0147 |
| Hi | COPD | N | 8.17×105 | 7.90×10−3 | 1.15×10−2 | 0.0129 | 0.0090 |
| non-COPD | 4.79×106 | N | |||||
| Kp | CAP | 6.93×104 | N | 1.34×10−18 | 3.30×10−12 | 0.0277 | 0.0171 |
| non-CAP | 3.69×106 | N | |||||
| Pa | BX | N | 3.33×106 | 2.71×10−45 | <2×10−16 | 0.0555 | 0.0285 |
| non-BX | 1.55×105 | 2.18×108 | |||||
| Sa | All | N | 5.40×105 | 2.62×10−29 | 1.84×10−10 | 0.0210 | 0.0129 |
| Sm | Aged | N | 1.47×105 | 2.02×10−5 | 1.34×10−4 | 0.0113 | 0.0061 |
| non-Aged | 1.13×106 | 2.18×108 | |||||
| Sp | Children | N | 1.19×104
| 7.35×10−21 | 1.01×10−9 | 0.0219 | 0.0134 |
| COPD adults | 2.15×104 | 1.15×107 | |||||
| non-COPD adults | 1.62×105 | 2.28×107 | |||||
Note: We only used the data from the three-time culture to test the consistency between qLAMP and culture assays. N and BX stand for not found and bronchiectasis, respectively.
In the piecewise linear regression of S. pneumoniae for child patients, all the detected titers were PCs (pathogen candidates), and no breakpoint was found. Therefore, the lowest titer detected in this subgroup is deemed as the upper cutoff.
Figure 3Examples of S. pneumonia showing the relationship between qLAMP and culture results (logistic regression) and cutoff determination based on competitive relationship (piece-wise linear regression).
The horizontal axis displays the bacterial natural logarithmic titer in sputum sample. (A) Logistic regression curve (green line). Solid circles indicate patients; they are placed at the top of the chart when being test as positive and at the bottom of the chart when being tested as negative in the culture assays. The height and width of the bars display the frequency and the number of patients being tested positive in cultures, respectively. (B) Piecewise linear regression (black lines) of S. pneumonia in COPD patients. Open circles indicate patients; they are placed at the top of the chart when being PC (Pathogen Candidate) and at the bottom of the chart when NOT being PC.
Figure 4The percentage of bacteria identified as definite (dark blue) and possible (light blue) causative agents in LRTI patients (for the full bacterial names see the legend of
). The patients are classified as: children, ≤14 yr; middle-aged adult, >14 yr but <70 yr; aged, ≥70 yr; AB, acute bronchitis; CAP, community acquired pneumonia; AECOPD, acute exacerbation of COPD; and AEBX, acute exacerbation of bronchiectasis.
Figure 5The qLAMP-based diagnostic rates in LRTI patients and different subgroups.